Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Background: Patients with breast cancer (BC) show strong interest in complementary and alternative medicine (CAM), particularly for adverse effects of adjuvant endocrine treatment — e.g., with letrozole. Letrozole often induces myalgia/limb pain and arthralgia, with potential noncompliance and treat...

Full description

Bibliographic Details

Published in:	Breast
Main Authors:	C.C. Hack, L. Häberle, S.Y. Brucker, W. Janni, B. Volz, C.R. Loehberg, A.D. Hartkopf, C.-B. Walter, G. Baake, A. Fridman, W. Malter, R. Wuerstlein, N. Harbeck, O. Hoffmann, S. Kuemmel, B. Martin, C. Thomssen, H. Graf, C. Wolf, M.P. Lux, C.M. Bayer, C. Rauh, K. Almstedt, P. Gass, F. Heindl, T. Brodkorb, L. Willer, C. Lindner, H.-C. Kolberg, P. Krabisch, M. Weigel, D. Steinfeld-Birg, A. Kohls, C. Brucker, V. Schulz, G. Fischer, V. Pelzer, B. Rack, M.W. Beckmann, T. Fehm, A. Rody, N. Maass, A. Hein, P.A. Fasching, N. Nabieva
Format:	Article
Language:	English
Published:	Elsevier 2020-04-01
Subjects:	Breast cancer Endocrine therapy/treatment Aromatase inhibitors Letrozole Integrative medicine Complementary and alternative medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977620300011